ArticleBMJ open2011

Heterogeneity of the efficacy of the 23-valent pneumococcal polysaccharide vaccine caused by various underlying conditions of chronic pulmonary disease in older patients: prospective cohort study.

Satoshi Inoue et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.